Dapagliflozin (Standard)
Dapagliflozin (Standard) is the analytical standard of Dapagliflozin. This product is intended for research and analytical applications. Dapagliflozin (BMS-512148), a new type of agent used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine[1]. Dapagliflozin induces HIF1 expression and attenuates renal IR injury[2].
Product Specifications
CAS Number
461432-26-8
Product Name Alternative
BMS-512148 (Standard)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Reference Standards; SGLT
Type
Reference Standards
Related Pathways
Membrane Transporter/Ion Channel; Others
Field of Research
Metabolic Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/dapagliflozin-standard.html
Purity
99.96
Smiles
O[C@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O
Molecular Formula
C21H25ClO6
Molecular Weight
408.87
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
4°C, sealed and dry storage, away from light and moisture
Scientific Category
Reference Standards
Isoform
SGLT2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD45 / LCA (2B11 + PD7/26), CF488A conjugate, 0.1mg/mL
